Hematology Cancer Consortium - Association Profile
Key Indicators
- Company Age 5 Year, 23 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 63.96%
- Profit Growth -64.29%
- Ebitda -74.59%
- Net Worth 11.25%
- Total Assets 45.35%
About Hematology Cancer Consortium - Association
Hematology Cancer Consortium - Association (HCCA) is a Private Not For Profit Company incorporated in India on 09 January 2020 (Five years 23 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Hematology Cancer Consortium - Association India is Bhavisha Sanadhya as CEO. Vikram, Palani Thyagarajan, and Niyati James serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100MH2020NPL335745
-
Company No.
335745
-
Company Classification
Private Not For Profit Company
-
Incorporation Date
09 Jan 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Hematology Cancer Consortium - Association?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhavisha Sanadhya | CEO | 08-Dec-2021 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikram
|
Director | 09-Jan-2020 | Current |
|
Palani Thyagarajan
|
Director | 08-Dec-2021 | Current |
|
Niyati James
|
Director | 08-Dec-2021 | Current |
Financial Performance of Hematology Cancer Consortium - Association.
Hematology Cancer Consortium - Association, for the financial year ended 2023, experienced significant growth in revenue, with a 63.96% increase. The company also saw a substantial fall in profitability, with a 64.29% decrease in profit. The company's net worth Soared by an impressive increase of 11.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hematology Cancer Consortium - Association?
Unlock access to Hematology Cancer Consortium - Association's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Advanced Medicinal Therapies Foundation (Amtf)Vikram is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hematology Cancer Consortium - Association?
Unlock and access historical data on people associated with Hematology Cancer Consortium - Association, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hematology Cancer Consortium - Association, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hematology Cancer Consortium - Association's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
